Organogenesis Holdings (ORGO) Raw Materials (2021 - 2026)
Organogenesis Holdings (ORGO) recorded quarterly Raw Materials of $14.5 million in Q1 2026, up 1.31% quarter-over-quarter from $14.3 million in Q4 2025, and up 4.59% on a YoY basis from $13.9 million in Q1 2025.
Organogenesis Holdings (ORGO) Raw Materials (2021 - 2026) Analysis & Trends
Organogenesis Holdings' Raw Materials history runs 6 years deep, the most recent figure standing at $14.5 million for Q1 2026.
- In Q1 2026, Raw Materials rose 4.59% year-over-year to $14.5 million; the TTM figure through Mar 2026 stood at $14.5 million (up 4.59% YoY), while the FY2025 annual figure was $14.3 million, up 8.2% from the prior year.
- Raw Materials was $14.5 million for Q1 2026 at Organogenesis Holdings, up from $14.3 million in the prior quarter.
- In the past five years, Raw Materials ranged from a high of $14.5 million in Q1 2026 to a low of $10.2 million in Q2 2022.
- Historically, Raw Materials has averaged $13.2 million across 5 years, with a median of $13.3 million in 2023.
- The sharpest annual moves came in 2022 and 2024: Raw Materials surged 36.12% in 2022, then fell 6.42% in 2024.
- A 5-year view of Raw Materials shows it stood at $12.3 million in 2022, then climbed by 5.75% to $13.0 million in 2023, then gained by 2.03% to $13.3 million in 2024, then advanced by 8.2% to $14.3 million in 2025, then climbed by 1.31% to $14.5 million in 2026.
- The last three Raw Materials figures came in at $14.5 million (Q1 2026), $14.3 million (Q4 2025), and $14.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Organogenesis Holdings | 304.80 Mn | 212.70 Mn | 11.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.53 Mn |
| Dec 31, 2025 | 14.34 Mn |
| Sep 30, 2025 | 14.09 Mn |
| Jun 30, 2025 | 13.92 Mn |
| Mar 31, 2025 | 13.89 Mn |
| Dec 31, 2024 | 13.25 Mn |
| Sep 30, 2024 | 13.02 Mn |
| Jun 30, 2024 | 13.67 Mn |
| Mar 31, 2024 | 13.34 Mn |
| Dec 31, 2023 | 12.99 Mn |
| Sep 30, 2023 | 13.91 Mn |
| Jun 30, 2023 | 13.27 Mn |
| Mar 31, 2023 | 13.13 Mn |
| Dec 31, 2022 | 12.28 Mn |
| Sep 30, 2022 | 10.96 Mn |
| Jun 30, 2022 | 10.23 Mn |
| Dec 31, 2021 | 9.02 Mn |